CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
Capsaicin 0.1% Cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03223350
NCT03223350Phase 2Completed
CompareCT.gov

Topical Capsaicin Cream for Treatment of Suspected Cyclical Vomiting Syndromes

Henry Ford Health System·interventional·Posted Jul 21, 2017·Updated Dec 15, 2021

In Brief

A Phase 2 clinical trial evaluating Capsaicin 0.1% Cream and Placebos for Cyclical Vomiting. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This is a phase 2 randomized controlled trial testing the effect of topical capsaicin for the relieve of nausea and vomiting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCyclical Vomiting
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJul 21, 2017
Enrollment StartDec 20, 2017
Primary CompletionAug 5, 2019
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.9 years ago

Interventions

Capsaicin 0.1% Creamdrug

Topical application

Placebosdrug

placebo cream